Rosacea risk higher in female migraine sufferers

Rosacea risk higher in female migraine sufferers

(HealthDay)—There is a slight increased risk of rosacea among females with migraines, according to a study published in the September issue of the Journal of the American Academy of Dermatology.

Julia Spoendlin, from the University of Basel in Switzerland, and colleagues used the United Kingdom-based General Practice Research Database to identify patients with incident rosacea between 1995 and 2009 (cases; 53,927 participants) and matched rosacea-free (matched 1:1; 53,927 participants).

The researchers observed a small overall association between rosacea and migraine in women (adjusted odds ratio [aOR], 1.22), but not in men. In female migraineurs aged 50 to 59 years, the effect was more pronounced (aOR, 1.36). Female triptan users also exhibited slightly increasing risk estimates with increasing age, with the highest odds ratio seen in women aged 60 years and older (aOR, 1.66).

"We observed a slightly increased risk for female migraineurs to develop rosacea, particularly in women with severe migraine aged 50 years or older," the authors write.

One author disclosed to Galderma, which funded the study.


Explore further

Epidemiology of rosacea described in United Kingdom

More information: Abstract
Full Text (subscription or payment may be required)

Copyright © 2013 HealthDay. All rights reserved.

Citation: Rosacea risk higher in female migraine sufferers (2013, September 20) retrieved 14 November 2019 from https://medicalxpress.com/news/2013-09-rosacea-higher-female-migraine.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
 shares

Feedback to editors

User comments